Tat_BioV: tattoo ink exposure and biokinetics of selected tracers in a short-term clinical study of 24 subjects
- PMID: 39888425
- PMCID: PMC11968518
- DOI: 10.1007/s00204-025-03959-8
Tat_BioV: tattoo ink exposure and biokinetics of selected tracers in a short-term clinical study of 24 subjects
Abstract
About one-fifth of people in industrialised countries are tattooed, potentially putting them at risk of exposure to possible carcinogenic or otherwise harmful substances. This study aims to determine the exposure to soluble tattoo ink ingredients and their excretion within 24 h after tattooing. In this clinical study, 24 subjects were tattooed with black or red tattoo ink to which the 3 tracer substances, potassium iodide, 4-aminobenzoic acid (PABA) and 2-phenoxyethanol (PEtOH), had been added to mimic known substances found in tattoo inks. Tracers and their metabolites were quantified in blood, urine, ink and consumables pre- and post-tattooing. Tattooed skin area was determined using picture analysis. PABA metabolism upon tattooing was compared to peroral administration. Skin fibroblasts and macrophages were tested in vitro for their ability to metabolise PABA. All tracers or their metabolites were identified in urine; iodide and the PABA metabolite 4-acetamidobenzoic acid (ACD) were identified in plasma. The worst-case scenario for systemic ink exposure was estimated to be 0.31 g ink per tattoo session (75th percentile). Peroral administration resulted in lower levels of ACD than tattooing. Fibroblasts and macrophages were capable of converting PABA into ACD. Our results are the first human in vivo data on soluble tattoo ink ingredients and suggest that the overall exposure might be lower than the estimates previously used for regulatory purposes. In addition, the first-pass effect by skin metabolism leads to an altered metabolite profile compared to oral exposure. Skin metabolism might also contribute to detoxification of certain carcinogenic substances through N-acetylation.
Keywords: Clinical study; Environmental exposure; Mass spectrometry; Metabolism; Skin; Tattooing.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Ethical approval: The study was approved by the ethics committee of the Charité—Universitätsmedizin Berlin (Berlin, Germany) under the proposal number EA4/085/21.
Figures




References
-
- Agnello M, Fontana M (2015) Survey on European studies of the chemical characterisation of tattoo ink products and the measurement of potentially harmful ingredients. Tattooed Skin Health. 10.1159/000369197 - PubMed
-
- Aparicio-Soto M, Riedel F, Leddermann M et al (2020) TCRs with segment TRAV9-2 or a CDR3 histidine are overrepresented among nickel-specific CD4+ T cells. Allergy 75(10):2574–2586. 10.1111/all.14322 - PubMed
-
- Arbache S, Mattos EdC, Diniz MF et al (2019) How much medication is delivered in a novel drug delivery technique that uses a tattoo machine? Int J Dermatol 58(6):750–755. 10.1111/ijd.14408 - PubMed
-
- Battistini B, Petrucci F, De Angelis I, Failla CM, Bocca B (2020) Quantitative analysis of metals and metal-based nano- and submicron-particles in tattoo inks. Chemosphere 245:125667. 10.1016/j.chemosphere.2019.125667 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources